Lycia Therapeutics Plans IPO of 14.7 Million Shares at $16–$18 Each
Lycia Therapeutics said it plans to sell 14.7 million shares in its initial public offering at $16 to $18 each. At the $17 midpoint, the company expects net proceeds of about $2…
By Colin KellaherLycia Therapeutics on Tuesday said it plans to sell 14.7 million shares at between $16 and $18 each in its initial public offering.At the $17 midpoint of that price range, the South San Francisco, Calif., clinical-stage biotechnology company said it expects net proceeds of about $2…